Cargando…
Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
BACKGROUND: Multiple sclerosis (MS) is a neuroinflammatory disease in which pregnancy leads to a temporary amelioration in disease activity as indicated by the profound decrease in relapses rate during the 3rd trimester of pregnancy. CD4(+) and CD8(+) T cells are implicated in MS pathogenesis as bei...
Autores principales: | Zenere, Alberto, Hellberg, Sandra, Papapavlou Lingehed, Georgia, Svenvik, Maria, Mellergård, Johan, Dahle, Charlotte, Vrethem, Magnus, Raffetseder, Johanna, Khademi, Mohsen, Olsson, Tomas, Blomberg, Marie, Jenmalm, Maria C., Altafini, Claudio, Gustafsson, Mika, Ernerudh, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134602/ https://www.ncbi.nlm.nih.gov/pubmed/37106402 http://dx.doi.org/10.1186/s12974-023-02781-2 |
Ejemplares similares
-
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy
por: Papapavlou Lingehed, Georgia, et al.
Publicado: (2022) -
Progesterone Dampens Immune Responses in In Vitro Activated CD4(+) T Cells and Affects Genes Associated With Autoimmune Diseases That Improve During Pregnancy
por: Hellberg, Sandra, et al.
Publicado: (2021) -
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
por: Åkesson, Julia, et al.
Publicado: (2023) -
Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients
por: Mellergård, Johan, et al.
Publicado: (2013) -
Preterm Birth: A Prominent Risk Factor for Low Apgar Scores
por: Svenvik, Maria, et al.
Publicado: (2015)